4883 · Modalis Therapeutics Corporation · Financials
Market Cap
3.13B JPY
Shares
104.37M
Volume · Nov 13
7.44M
Avg daily vol (3M)
1.77M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Net Income
-2.15B
-63.3%
FY2025
Operating Cash Flow
-2.12B
-47.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | -2.21B | -1.34B | -2.37B | -2.06B | -1.24B |
| JPY | -2.15B | -1.32B | -2.39B | -2.71B | -745.42M |
| JPY | 1.54M | 965K | 1.21M | -4.32M | -6.46M |
| JPY | -2.15B | -1.32B | -2.39B | -2.7B | -738.96M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.